BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ronot M, Leporq B, Van Beers BE, Vilgrain V. CT and MR perfusion techniques to assess diffuse liver disease. Abdom Radiol (NY) 2020;45:3496-506. [PMID: 31768595 DOI: 10.1007/s00261-019-02338-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Im WH, Song JS, Jang W. Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques. Abdom Radiol (NY) 2021. [PMID: 34228199 DOI: 10.1007/s00261-021-03181-x] [Reference Citation Analysis]
2 Pastor CM, Joly F, Vilgrain V, Millet P. Concentrations and pharmacokinetic parameters of MRI and SPECT hepatobiliary agents in rat liver compartments. Eur Radiol Exp 2021;5:42. [PMID: 34545428 DOI: 10.1186/s41747-021-00236-y] [Reference Citation Analysis]
3 Hou J, Wong VW, Qian Y, Jiang B, Chan AW, Leung HH, Wong GL, Yu SC, Chu WC, Chen W. Detecting Early-Stage Liver Fibrosis Using Macromolecular Proton Fraction Mapping Based on Spin-Lock MRI: Preliminary Observations. J Magn Reson Imaging 2022. [PMID: 35753084 DOI: 10.1002/jmri.28308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vernuccio F, Cannella R, Bartolotta TV, Galia M, Tang A, Brancatelli G. Advances in liver US, CT, and MRI: moving toward the future. Eur Radiol Exp 2021;5:52. [PMID: 34873633 DOI: 10.1186/s41747-021-00250-0] [Reference Citation Analysis]